The notices it replaced
- Reissues: PAR-22-036 Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
- 2 steps back: RFA-MH-21-106 Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
Replaced by PAR-25-282.
Who won it before
1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $233,250 in first-year total cost, median $233,250.
Most frequent study sections
- Special Emphasis Panel[ZMH1 ERB-N (07)]1
Most frequent institutions
- UNIV OF NORTH CAROLINA CHAPEL HILL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Identifying neurophysiological mechanisms of susceptibility to estradiol fluctuation and irritability symptoms in the menopause transition: An experimental approach1R21MH128241-01 · under RFA-MH-21-106 | ANDERSEN, ELIZABETH HELENGIRDLER, SUSAN S. | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $233,250 | ZMH1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.